Companies › Remedy Robotics

OEM · San Francisco

Remedy Robotics

Develops the N1 robotic catheter system for emergency neurointerventional procedures such as thrombectomies.

Official site ↗

About

Remedy Robotics builds an AI-powered endovascular robotic system for endovascular intervention. The company presents its work as a response to cardiovascular diseases such as stroke, heart attack and bleeding, and notes that endovascular intervention is the gold-standard treatment that remains out of reach for most patients; the page states that fewer than 3% of eligible stroke patients worldwide can access timely endovascular intervention. The Remedy system is described as providing physicians with tool control and 3D visualization, and as including teleoperation and automation to extend expert care. The page states Remedy Robotics has achieved world-first clinical milestones, including entirely robotic neurointerventional procedures and entirely remotely controlled neurointerventional procedures.

Summary drawn from the official website, reviewed 2026-11-21.

Recent developments

  • · funding

    Announced US $62 million in new funding to support upcoming clinical trials; a portion of the investment came from the University of California system. Source: spectrum.ieee.org

In our stories

No published story names this company yet.

← All companies